Innovative Microbial Platform BIOMILLENIA’s proprietary microfluidic platform enables rapid identification and characterization of microbes with functional traits, offering a valuable solution for biotech, pharma, agriculture, and environmental companies seeking to accelerate microbial research and development.

Strategic Collaborations The company's history of partnerships with industry leaders like BASF, Amyris, and Qiagen highlights its credibility and attractiveness to organizations looking to integrate cutting-edge microbiome and microbial genomics technologies into their pipelines.

Market Expansion Potential With recent service launches such as microbiome culture collections and a focus on restoring resilient microbiota, BIOMILLENIA is well-positioned to serve growing markets in health, agriculture, and environmental sustainability.

Early Revenue Stage Currently generating up to $1 million in revenue, BIOMILLENIA presents an opportunity for partners interested in early-stage biotech innovations with significant growth potential through strategic investments or pilot projects.

Niche Focus and Expertise Specializing in ultra-high-throughput single-cell microbial assays and microbiome engineering, BIOMILLENIA offers tailored solutions that can complement existing R&D efforts, opening doors for collaborations across various segments of life sciences.